Of the 179 known BC susceptibility SNPs identified through GWAS in the general population5–35, only 10 showed evidence of interaction with BRCA1 or BRCA2 mutation carrier status after taking the tumour ER-status into account. Here, BRCA2 is linked to neoplasm.